Skip to main content
. 2022 Feb 9;10:832059. doi: 10.3389/fbioe.2022.832059

FIGURE 5.

FIGURE 5

RP-LC-MS based primary structure biosimilarity assessment of trastuzumab originator and biosimilars as adapted from Joshi and Rathore, 2020. (A) mirror plot of Intact profile, (B) mirror plot of reduced profile and (C) stacked chromatograms of trastuzumab biosimilars compared with originator.